Market Price

115.50 

-2.65 -2.2%

as of Feb 25 '20

52 Week Range:

86.16 125.55


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for use in the discovery, development, and manufacture of drug therapies, as well as in laboratories; and specialty chemicals for use in displays, computer chips, surfaces, Integrated circuits, microelectronic systems, anti-reflection coatings, and cosmetics. It has alliances with Pfizer Inc., Bristol-Myers Squibb Company, Intrexon Corporation, Avillion LLP., F-star Delta Ltd, SFJ Pharmaceuticals Group, Alibaba Health, Checkmate Pharmaceuticals, Solvias, and Leap Therapeutics, Inc.; a collaboration with Daiichi Sankyo Company, Limited and BioMed X Innovation Center; a co-development agreement with Oncolytics Biotech Inc.; a partnership with GlucoMe LTD; and collaboration agreements with Phosplatin Therapeutics LLC and Vyriad Inc. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 19.84
21.86
24.09
23.90
24.18
24.69
26.98
32.10
29.72
31.58
35.15
growth rate 10.2% 10.2% -0.8% 1.2% 2.1% 9.3% 19.0% -7.4% 6.3% 11.3%
Earnings BIT 574.90
486.40
861.10
851.10
709.00
2,079.30
1,833.50
2,232.00
2,457.00
2,413.00
1,936.00
growth rate -15.4% 77.0% -1.2% -16.7% 193.3% -11.8% 21.7% 10.1% -1.8% -19.8%
Avg.PE 38.17
38.61
20.58
27.10
38.31
23.53
36.94
26.17
27.74
13.12
12.70
growth rate 1.2% -46.7% 31.7% 41.4% -38.6% 57.0% -29.2% 6.0% -52.7% -3.2%
ROA 2.40
2.26
3.23
2.77
2.59
5.66
4.94
3.48
4.27
7.04
9.31
growth rate -5.8% 42.9% -14.2% -6.5% 118.5% -12.7% -29.6% 22.7% 64.9% 32.2%
ROE 4.05
3.86
6.39
5.94
5.45
11.25
10.17
9.09
12.17
18.58
21.63
growth rate -4.7% 65.5% -7.0% -8.3% 106.4% -9.6% -10.6% 33.9% 52.7% 16.4%
ROIC 4.05
3.86
6.39
5.94
5.33
9.48
8.11
6.19
7.10
11.05
14.13
growth rate -4.7% 65.5% -7.0% -10.3% 77.9% -14.5% -23.7% 14.7% 55.6% 27.9%
Cur. Ratio 1.83
1.96
1.68
1.47
1.45
1.89
1.59
0.78
0.84
0.86
1.08
growth rate 7.1% -14.3% -12.5% -1.4% 30.3% -15.9% -50.9% 7.7% 2.4% 25.6%
Quick Ratio 1.06
1.36
0.98
1.00
1.03
1.41
1.12
0.42
0.46
0.44
0.64
growth rate 28.3% -27.9% 2.0% 3.0% 36.9% -20.6% -62.5% 9.5% -4.4% 45.5%
Leverage 1.65
1.77
2.17
2.12
2.09
1.89
2.22
2.97
2.73
2.54
2.14
growth rate 7.3% 22.6% -2.3% -1.4% -9.6% 17.5% 33.8% -8.1% -7.0% -15.8%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 1,659.40
1,788.70
2,887.00
3,334.00
2,674.00
2,371.30
2,882.30
3,460.00
3,811.00
3,945.00
4,056.00
growth rate 7.8% 61.4% 15.5% -19.8% -11.3% 21.6% 20.0% 10.1% 3.5% 2.8%
Acct.Payable 1,200.00
1,101.00
1,288.00
1,364.10
1,539.40
1,921.00
2,048.00
2,195.00
1,766.00
growth rate -8.3% 17.0% 5.9% 12.9% 24.8% 6.6% 7.2% -19.5%
Cur.Assets 4,358.70
5,532.10
5,664.00
6,399.00
6,626.00
7,384.50
10,480.40
7,344.00
7,670.00
7,455.00
9,236.00
growth rate 26.9% 2.4% 13.0% 3.6% 11.5% 41.9% -29.9% 4.4% -2.8% 23.9%
Total Assets 15,644.70
16,712.60
22,388.00
22,122.00
21,643.00
20,818.60
26,010.10
38,081.00
38,258.00
35,621.00
36,888.00
growth rate 6.8% 34.0% -1.2% -2.2% -3.8% 24.9% 46.4% 0.5% -6.9% 3.6%
Cash 692.70
541.40
944.00
938.00
730.00
980.80
2,878.50
832.00
939.00
589.00
2,170.00
growth rate -21.8% 74.4% -0.6% -22.2% 34.4% 193.5% -71.1% 12.9% -37.3% 268.4%
Inventory 1,407.40
1,367.90
1,674.00
1,691.00
1,534.00
1,474.20
1,659.70
2,610.00
2,609.00
2,632.00
2,764.00
growth rate -2.8% 22.4% 1.0% -9.3% -3.9% 12.6% 57.3% 0.0% 0.9% 5.0%
Cur.Liabilities 2,378.40
2,820.00
3,360.00
4,362.00
4,562.00
3,898.80
6,601.40
9,384.00
9,089.00
8,635.00
8,517.00
growth rate 18.6% 19.2% 29.8% 4.6% -14.5% 69.3% 42.2% -3.1% -5.0% -1.4%
Liabilities 6,081.70
7,252.50
12,016.00
11,628.00
11,229.00
9,749.40
14,209.10
25,226.00
24,208.00
21,555.00
19,655.00
growth rate 19.3% 65.7% -3.2% -3.4% -13.2% 45.7% 77.5% -4.0% -11.0% -8.8%
LT Debt 1,080.10
0.00
5,122.00
4,136.00
3,355.00
3,252.10
3,557.40
9,613.00
8,807.00
8,031.00
6,679.00
growth rate -100.0% -19.3% -18.9% -3.1% 9.4% 170.2% -8.4% -8.8% -16.8%
Equity 9,563.00
9,513.60
10,376.60
10,494.30
10,414.80
11,020.00
11,741.60
12,787.00
13,989.00
14,003.00
17,200.00
growth rate -0.5% 9.1% 1.1% -0.8% 5.8% 6.6% 8.9% 9.4% 0.1% 22.8%
Common Shares 435.00
435.00
435.00
435.00
434.00
434.00
435.00
436.00
434.00
435.00
435.00
growth rate 0.0% 0.0% 0.0% -0.2% 0.0% 0.2% 0.2% -0.5% 0.2% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 359.00
421.90
396.00
366.00
329.00
407.00
480.90
514.00
716.00
919.00
910.00
growth rate 17.5% -6.1% -7.6% -10.1% 23.7% 18.2% 6.9% 39.3% 28.4% -1.0%
Cash Dividends 212.50
104.80
86.10
86.80
96.90
414.40
505.50
564.00
597.00
621.00
755.00
growth rate -50.7% -17.8% 0.8% 11.6% 327.7% 22.0% 11.6% 5.9% 4.0% 21.6%
Cash From OA 1,024.00
1,371.30
1,783.00
1,271.00
2,472.00
2,225.50
2,705.50
2,195.00
2,518.00
2,696.00
2,219.00
growth rate 33.9% 30.0% -28.7% 94.5% -10.0% 21.6% -18.9% 14.7% 7.1% -17.7%
FCF per Share 1.89
1.12
2.67
2.80
3.90
3.85
3.32
4.38
3.81
3.76
2.35
growth rate -40.7% 138.4% 4.9% 39.3% -1.3% -13.8% 31.9% -13.0% -1.3% -37.5%
FCF 488.00
807.00
1,282.00
825.00
1,999.00
1,709.00
2,081.00
1,502.00
1,670.00
1,385.00
1,203.00
growth rate 65.4% 58.9% -35.7% 142.3% -14.5% 21.8% -27.8% 11.2% -17.1% -13.1%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 7,589.60
7,747.00
9,291.00
10,276.00
11,173.00
11,095.10
11,362.80
12,845.00
15,024.00
14,517.00
14,836.00
growth rate 2.1% 19.9% 10.6% 8.7% -0.7% 2.4% 13.0% 17.0% -3.4% 2.2%
Op.Income 731.40
645.40
642.00
618.00
579.00
2,079.30
1,833.50
2,232.00
2,457.00
2,413.00
1,936.00
growth rate -11.8% -0.5% -3.7% -6.3% 259.1% -11.8% 21.7% 10.1% -1.8% -19.8%
IBT 574.90
486.40
861.10
838.80
709.00
1,388.60
1,557.00
1,486.00
2,154.00
2,130.00
1,461.00
growth rate -15.4% 77.0% -2.6% -15.5% 95.9% 12.1% -4.6% 45.0% -1.1% -31.4%
Net Income 379.10
376.70
642.00
618.00
579.00
1,202.20
1,157.30
1,115.00
1,629.00
2,605.00
3,374.00
growth rate -0.6% 70.4% -3.7% -6.3% 107.6% -3.7% -3.7% 46.1% 59.9% 29.5%
EPS 0.84
0.84
1.46
1.40
1.30
2.77
2.66
2.56
3.75
5.99
7.76
growth rate 0.0% 73.8% -4.1% -7.1% 113.1% -4.0% -3.8% 46.5% 59.7% 29.6%
Gross Profit 5,683.60
5,717.70
6,514.00
7,043.00
7,435.00
7,486.40
7,896.90
8,800.00
9,823.00
9,446.00
9,454.00
growth rate 0.6% 13.9% 8.1% 5.6% 0.7% 5.5% 11.4% 11.6% -3.8% 0.1%
R&D 1,234.40
1,344.60
1,514.00
1,511.30
1,506.60
1,703.70
1,709.00
1,976.00
2,108.00
2,225.00
growth rate 8.9% 6.1% -0.2% -0.3% 13.1% 0.3% 15.6% 6.7% 5.6%

Quarterly Statements

Item Name Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Earnings BIT 459.00
575.00
409.00
615.00
607.00
growth rate 25.3% -28.9% 50.4% -1.3%
Balance Sheet Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Acct.Receivable 3,354.00
4,056.00
4,045.00
3,772.00
3,765.00
growth rate 20.9% -0.3% -6.8% -0.2%
Acct.Payable 2,057.00
1,766.00
1,633.00
1,737.00
1,736.00
growth rate -14.2% -7.5% 6.4% -0.1%
Cur.Assets 8,355.00
9,236.00
10,512.00
11,694.00
13,518.00
growth rate 10.5% 13.8% 11.2% 15.6%
Total Assets 35,740.00
36,888.00
38,717.00
39,568.00
42,067.00
growth rate 3.2% 5.0% 2.2% 6.3%
Cash 833.00
2,170.00
2,340.00
3,451.00
5,111.00
growth rate 160.5% 7.8% 47.5% 48.1%
Inventory 2,814.00
2,764.00
2,937.00
3,033.00
3,135.00
growth rate -1.8% 6.3% 3.3% 3.4%
Cur.Liabilities 8,966.00
8,517.00
11,194.00
10,495.00
9,655.00
growth rate -5.0% 31.4% -6.2% -8.0%
Liabilities 20,393.00
19,655.00
21,042.00
21,994.00
23,885.00
growth rate -3.6% 7.1% 4.5% 8.6%
LT Debt 7,095.00
6,679.00
5,047.00
6,165.00
8,614.00
growth rate -5.9% -24.4% 22.2% 39.7%
Equity 15,283.00
17,200.00
17,640.00
17,550.00
18,158.00
growth rate 12.5% 2.6% -0.5% 3.5%
Common Shares 565.00
565.00
565.00
565.00
565.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Capital Expenditures 215.00
299.00
209.00
165.00
194.00
growth rate 39.1% -30.1% -21.1% 17.6%
Cash Dividends 61.00
61.00
61.00
616.00
growth rate 0.0% 0.0% 909.8%
Cash From OA 731.00
740.00
493.00
743.00
931.00
growth rate 1.2% -33.4% 50.7% 25.3%
FCF 516.00
441.00
284.00
578.00
737.00
growth rate -14.5% -35.6% 103.5% 27.5%
Income Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Sales 3,749.00
3,887.00
3,746.00
3,971.00
4,054.00
growth rate 3.7% -3.6% 6.0% 2.1%
Op.Income 459.00
575.00
409.00
615.00
607.00
growth rate 25.3% -28.9% 50.4% -1.3%
IBT 435.00
257.00
267.00
557.00
474.00
growth rate -40.9% 3.9% 108.6% -14.9%
Net Income 340.00
2,446.00
189.00
471.00
343.00
growth rate 619.4% -92.3% 149.2% -27.2%
EPS
growth rate
Gross Profit 2,405.00
2,430.00
2,362.00
2,517.00
2,576.00
growth rate 1.0% -2.8% 6.6% 2.3%
R&D 542.00
637.00
527.00
553.00
558.00
growth rate 17.5% -17.3% 4.9% 0.9%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (43.58)

YOY Growth Grade:

D (36.68)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 15.59 14.52 22.14
EPS / Growth 320.4% 7.96 20.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 9.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 9.9% 15.0% 15.0%
Future PE 15.59 22.58 22.58
Future EPS 20.41 32.19 32.19
Value Price
MOS %
78.66
-31.9%
179.63
55.5%
179.63
55.5%
MOS Price 39.33 89.81 89.81
IRT 8.86 7.59 7.59

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.